Cargando…
Successful apatinib treatment for advanced clear cell renal carcinoma as a first-line palliative treatment: A case report
BACKGROUND: Apatinib is an orally bioavailable small-molecule receptor tyrosine kinase inhibitor. In December 2014, the China Food and Drug Administration made it the first anti-angiogenic therapy to be approved for treating metastatic gastric cancer. It was specifically designated as a third-line o...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048545/ https://www.ncbi.nlm.nih.gov/pubmed/35582051 http://dx.doi.org/10.12998/wjcc.v10.i11.3593 |